MedTrace Logo

Comparison Between Intranasal vs Intravenous Dexmedetomidine for EEG Sedation of Children With Behavior Disorders.

NCT06434428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2024-05-30

No results posted yet for this study

Summary

The aim of the project was to compare the efficacy and safety of intranasal (IN) and intravenous (IV) dexmedetomidine (DEX) in procedural sedation for electroencephalogram (EEG) in pediatric patients with behavioural disorders.

Single-centre comparative observational study in the tertiary care centre of Padua, regarding all consecutive pediatric patients affected by behavioural disorders, who needed sedation for EEG recording. A group of children received IV administration of DEX, the following year a second group of children received IN administration of the same drug. Target of sedation was level 2, according to the Paediatric Sedation State Scale (PSSS).

Conditions

  • Sedation Complication

Interventions

DRUG

dexmedetomidine (IV)

Administration of IV dexmedetomidine

DRUG

dexmedetomidine (IN)

Administration of IN dexmedetomidine

Sponsors & Collaborators

  • Azienda Ospedaliera di Padova

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2021-08-30
Completion
2022-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06434428 on ClinicalTrials.gov